ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026
Serum Uric Acid-to-Creatinine Ratio Is Independently Associated with Sudomotor Dysfunction in Type 2 Diabetes: A Cross-Sectional Study.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study investigated the association between the serum uric acid-to-creatinine ratio (SUA/Cr) and sudomotor dysfunction in patients with type 2 diabetes mellitus. Patients and Methods: This was a single-center, inpatient, cross-sectional study. A total of 781 participants were classified into three tertiles based on their SUA/Cr. The electrochemical conductivity (ESC) of sweat obtained from the hands and feet was measured using SUDOSCAN to assess sudomotor function. Mean ESC values for the hands (HESC) and feet (FESC) were computed independently. Sudomotor dysfunction was defined as HESC or FESC ≤ 60 μS. Statistical analyses were performed using SPSS 25.0, involving one-way ANOVA, Kruskal-Wallis test, chi-square test, Spearman correlation coefficient, binary/multivariable logistic regression (with three adjusted models), and subgroup analysis, with statistical significance defined as Results: The prevalence of sudomotor dysfunction in the first, second, and third tertiles of SUA/Cr was 65.0%, 57.6%, and 48.9%, respectively. Patients with lower SUA/Cr levels exhibited a markedly increased risk of sudomotor dysfunction compared to those with higher SUA/Cr levels (p < 0.001). After adjusting for potential confounders, the association between decreased SUA/Cr ratio and sudomotor dysfunction risk remained significant (OR=1.646, 95% CI: 1.088-2.489, p = 0.018). Subgroup analyses by age, sex, glycated hemoglobin A1c, body mass index, and duration of diabetes confirmed the robustness of the relationship between SUA/Cr and the risk of diabetic peripheral neuropathy (all interactions p > 0.05). Conclusion: The SUA/Cr ratio is independently associated with sudomotor dysfunction in patients with type 2 diabetes mellitus.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.